Scott Rocklage is a healthcare management expert currently serving at 5AM Ventures in the capacity of managing partner. Rocklage became part of 5AM Ventures’ professional team back in 2003 as venture partner. Throughout his 30-year career in healthcare management, he served in different capacities at a number of companies. He also oversaw the Food and Drug Administration approval of drugs like Omniscan, Cubicin, and Teslascan.
Rocklage’s Healthcare Management Career
Cubist Pharmaceuticals carried out multiple clinical trials under Scott Rocklage’s board chair and CEO tenure. Rocklage was also involved with Nycomed Salutar as an executive officer and president and Relypsa as board chair. He held executive chairperson roles at companies like Ilypsa, Semprus, and Mikana. He currently serves in the capacity of board chairperson at Rennovia, Cidara, and Kinestral. Rocklage is also a member of the boards of Epirus and Pulmatrix. Today, more than 30 U.S. patents are registered under his name.
Rocklage’s successful healthcare management career is attributed to his Ph.D. in chemistry that he earned from MIT. Rocklage was among the doctoral students who had the pleasure to conduct part of their doctoral research from MIT’s famous Richard Schrock chemistry lab. Before his enrollment at MIT, he graduated from the University of California, Berkeley with an undergraduate degree in chemistry. He has writing credits in over 100 peer-reviewed articles.
Tenure at 5AM Ventures
5AM Ventures is a reputable venture capital firm with interests in early-stage start-ups in the healthcare industry. The firm strives to be a leading provider of venture capital to start-up owners with potential. It is also on a mission of revolutionizing the company formation business. Through its life science-based solutions, 5AM manages to be on top of this business.
In his position as managing partner, Scott Rocklage interacts and works with ambitious entrepreneurs to mold their ideas into brilliant medicinal inventions. By shaping their ideas, Rocklage expects these entrepreneurs to come up with potential treatments or drugs to address unmet medical needs. He advises them to be well organized in terms of prioritization, calendaring and time management. He also advises them to embrace measured risk-taking and focus on recruiting people with the potential to foster growth in their start-ups.
Visit http://5amventures.com/team/scott-m-rocklage-phd/ to learn more.